Efficacy of DYRK1A inhibitors in novel models of Down syndrome acute lymphoblastic leukemia

Shannon L. Carey-Smith; Maryam H. Simad; Kunjal Panchal; Carlos Aya-Bonilla; Hannah Smolders; Sang Lin; Jesse D. Armitage; Vivien T. Nguyen; Kathryn Bentley; Jette Ford; Sajla Singh; Joyce Oommen; Anouchka P. Laurent; Thomas Mercher; John D. Crispino; Andrew P. Montgomery; Michael Kassiou; Thierry Besson; Emmanuel Deau; Laurent Meijer; Laurence C. Cheung; Rishi S. Kotecha; Sébastien Malinge

ArticleOPEN ACCESS

Efficacy of DYRK1A inhibitors in novel models of Down syndrome acute lymphoblastic leukemia

Haematologica

DOI: 10.3324/haematol.2023.284271

8Citations

11Readers

Cite

CITATION STYLE

APA

Carey-Smith, S. L., Simad, M. H., Panchal, K., Aya-Bonilla, C., Smolders, H., Lin, S., … Malinge, S. (2024, July 1). Efficacy of DYRK1A inhibitors in novel models of Down syndrome acute lymphoblastic leukemia. Haematologica. Ferrata Storti Foundation. https://doi.org/10.3324/haematol.2023.284271

Efficacy of DYRK1A inhibitors in novel models of Down syndrome acute lymphoblastic leukemia

Cite

Register to see more suggestions